Firestone to Remain Exclusive Tire of NTT IndyCar Series

Posted: Updated:
(photo courtesy of INDYCAR) (photo courtesy of INDYCAR)
INDIANAPOLIS -

Indianapolis-based  INDYCAR and Bridgestone Americas Inc.have signed a five-year partnership extension.The deal will keep Firestone the official tire of the NTT IndyCar Series and the Indianapolis 500 through 2025.

Firestone will enter its 20th consecutive season as the official tire supplier of the racing series, after more than eight decades in racing. 

“Champions have relied on Firestone tires for more than a century, and racing has always been the ideal proving ground for new technologies that help us evolve and advance our company’s passenger tire offerings,” said Philip Dobbs, chief marketing officer, Bridgestone Americas Tire Operations. “As the NTT IndyCar Series continues gaining momentum, we are introducing new fans to the Firestone brand and strengthening our relationship with the drivers who use our durable, dependable Firestone tires.”

The company is also the title sponsor of two events on the 2019 schedule, the Firestone Grand Prix of St. Petersburg on March 10 opens the season and the final race of the season, the Firestone Grand Prix of Monterey at WeatherTech Raceway Laguna Seca, on September 22.

  • Perspectives

    • Owe Taxes? What Went Wrong in 2018 and How to Survive It

      The 2018 tax filing deadline came and went. Whew! But for some Americans, the tax headache has just begun. This year was the first filing under the Tax Cuts and Jobs Act and while some taxpayers saw larger refunds others received a rude awakening. If you’re reeling from a large tax burden, this article is for you. The Root of the Problem Remember how excited you were when you received your first paycheck—followed by dismay when you saw how much was taken out for taxes.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Photo of Gary City Hall courtesy of the City of Gary

      McDermott Details Gary Retail Desert

      The city of Gary is facing challenges as it tries to rejuvenate retail business in the city. In an interview with our partners at The Times of Northwest Indiana, Aaron McDermott, president of Latitude Commercial Real Estate Services in Schererville, says the challenge is due to the perception, proximity and demographics associated with Gary. 

    • The Landing project involves redeveloping seven buildings and two parking lots into a mixed-use development.

      New Restaurant Concept Coming to The Landing

      The developers of a $34 million redevelopment project in downtown Fort Wayne have announced a new partnership. Cincinnati-based The Model Group says it is working with Cunningham Restaurant Group to bring a "new and unique" restaurant experience to The Landing.

    • Ball State Among '30 Best Online MBA Degree Programs'

      Ball State University’s Miller College of Business has been recognized as one of The 30 Best Online MBA Degree Programs by MBA Central. The website details 30 programs across the nation and praises Ball State’s program for its variety and affordability.

    • Ryan Wagoner

      Profit With a Purpose: The Rise of Social Impact Investing

      Social impact investing is a fast-growing sector driven by investors who want to use private capital to further the public good. This industry provides a unique opportunity for results-oriented social entrepreneurs to invest in businesses, funds and nonprofits with the intention of generating positive, measurable social change alongside financial return. By engaging in impact investing, investors can align their investment portfolios with their philanthropic priorities.

    • Lilly and Avidity Biosciences Announce Partnership

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Avidity Biosciences Inc. have announced a new partnership. The global licensing and research collaboration will work toward the discovery, development and commercialization of new medicines in immunology and other areas.